Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord mesenchymal stem cells (Indonesia University)
- Development stage
- Unknown
- Lead developer
- Universitas Indonesia
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
An investigational allogenic cell therapy consisting of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) developed by Indonesia University (Universitas Indonesia) in collaboration with Cipto Mangunkusumo Hospital. This biologic therapy is designed for the treatment of knee osteoarthritis and is administered via intra-articular injection, typically at a dose of 10 million cells. The therapy leverages the immunomodulatory and regenerative properties of mesenchymal stem cells to reduce joint inflammation and facilitate the repair of damaged articular cartilage. Clinical research has evaluated its efficacy both as a standalone treatment and when combined with other agents such as recombinant human growth hormone (somatotropin) or hyaluronic acid.
- Other names
- hUC-MSCsallogenic umbilical cord mesenchymal stem cellshuman umbilical cord-derived mesenchymal stem cells
Beyond the preview
Go deeper on umbilical cord mesenchymal stem cells (Indonesia University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord mesenchymal stem cells (Indonesia University).